BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 647626)

  • 1. The effects of treatment on delayed cutaneous hypersensitivity responses (DNCB, croton oil, and recall antigen) in patients with genitourinary cancer.
    Elhilali MM; Brosman SA; Vescera C; Paul JG; Fahey JL
    Cancer; 1978 May; 41(5):1765-70. PubMed ID: 647626
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous response to dinitrochlorobenzene in patients with genito-urinary cancers.
    Duclos H; Schwarzenberg L; Duclos SH; Hugues H; Kuss R
    Biomedicine; 1977 Jan; 27(1):43-7. PubMed ID: 856314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin testing in genitourinary carcinoma: 2-year followup.
    Decenzo JM; Allison R; Leadbetter GW
    J Urol; 1975 Aug; 114(2):271-3. PubMed ID: 1171996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response in bladder cancer patients.
    Brosman S; Elhilali M; Vescera C; Fahey J
    J Urol; 1979 Feb; 121(2):162-9. PubMed ID: 423328
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum ribonuclease in urologic cancer. Relation to host immunocompetence.
    Catalona WJ; Chretien PB; Matthews WJ; Tarpley JL
    Urology; 1973 Nov; 2(5):577-81. PubMed ID: 4797457
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic value of host immunocompetence in urologic cancer patients.
    Catalona WJ; Smolev JK; Harty JI
    J Urol; 1975 Dec; 114(6):922-6. PubMed ID: 1195475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of radial radiotherapy on delayed hypersensitivity and the inflammatory response.
    Ghossein NA; Bosworth JL; Bases RE
    Cancer; 1975 Jun; 35(6):1616-20. PubMed ID: 1148994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune evaluation with skin testing. A study of testicular, prostatic, and bladder neoplasms.
    Schellhammer PF; Bracken RB; Bean MA; Pinsky CM; Whitmore WF
    Cancer; 1976 Jul; 38(1):149-56. PubMed ID: 947511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoembryonic antigen in patients with urologic cancers.
    Guinan P; Ablin RJ; Barakat H; John T; Sadoughi N; Bush IM
    Urol Res; 1973 Oct; 1(3):101-5. PubMed ID: 4804082
    [No Abstract]   [Full Text] [Related]  

  • 10. Skin testing for prognosis or therapy formulation in cancer patients: caveat emptor.
    Mandel MA
    Plast Reconstr Surg; 1976 May; 57(5):621-6. PubMed ID: 1273144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel immunotherapies in GU malignancies.
    Drakaki A; McDermott DF
    Curr Oncol Rep; 2013 Jun; 15(3):224-31. PubMed ID: 23519772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cancer associated antigen test as an index to failure of complete removal of urological cancers.
    Wechsler M; Gerfo PL; Feminella J; Lattimer JK
    J Urol; 1973 Apr; 109(4):699-701. PubMed ID: 4735168
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunologic features of genitourinary cancer.
    Javadpour N
    Urology; 1973 Aug; 2(2):103-8. PubMed ID: 4129366
    [No Abstract]   [Full Text] [Related]  

  • 14. Colonic basophil hypersensitivity.
    Askenase PW; Boone WT; Binder HJ
    J Immunol; 1978 Jan; 120(1):198-301. PubMed ID: 627717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen and urothelial carcinoma.
    Hall RR; Laurence DJ; Neville AM; Wallace DM
    Br J Urol; 1973 Feb; 45(1):88-92. PubMed ID: 4690154
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunobiology of genitourinary tumors.
    Lange PH; Hakala TR; Fraley EE
    Urology; 1973 Nov; 2(5):485-92. PubMed ID: 4358375
    [No Abstract]   [Full Text] [Related]  

  • 17. An Overview of Emerging Immunotargets of Genitourinary Tumors.
    Montironi R; Santoni M; Cheng L; Lopez-Beltran A; Massari F; Matrana MR; Moch H; Scarpelli M
    Curr Drug Targets; 2016; 17(7):750-6. PubMed ID: 26648079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunology of genitourinary tumors.
    Guinan P; Sadoughi N; Bush IM; John T; Eghrari F; Ablin RJ
    Urology; 1973 Nov; 2(5):493-9. PubMed ID: 4131868
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunologic alterations in patients with prostatic carcinoma.
    Brosman S; Hausman M; Shacks S
    J Urol; 1975 Jun; 113(6):841-5. PubMed ID: 1152159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum immunoglobulins in genitourinary malignancies.
    Schmidt JD; Feldbush TL; Weinstein SH; Bonney WW
    J Urol; 1976 Mar; 115(3):293-5. PubMed ID: 943578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.